Co-Authors
This is a "connection" page, showing publications co-authored by JEFFREY ROSEN and Alex Smith.
Connection Strength
1.877
-
MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9+ monocyte-macrophage programming and durable anti-tumor immunity in triple negative breast cancer. bioRxiv. 2026 Feb 06.
Score: 0.978
-
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers. Nat Commun. 2026 Jan 03; 17(1):1193.
Score: 0.243
-
Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers. bioRxiv. 2025 May 06.
Score: 0.232
-
CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC. bioRxiv. 2024 Apr 27.
Score: 0.216
-
Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. bioRxiv. 2023 Sep 28.
Score: 0.208